CurrentEndo coverage · page 32 of 55

Diabetes, Obesity and Metabolism

Briefs 1,241–1,280 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

Diabetes Obes Metab5 Feb 2025
Identification of growth differentiation factor 15 as an early predictive biomarker for metabolic dysfunction‐associated steatohepatitis: A nested case–control study of UK Biobank proteomic data
Case-control studyLipids & liver
Diabetes Obes Metab4 Feb 2025
Effect of iGlarLixi on continuous glucose monitoring—measured time in range in insulin‐naive adults with suboptimally controlled type 2 diabetes
Research articleT2D & other
Diabetes Obes Metab4 Feb 2025
MiniMed 780G system performance in older users with type 1 diabetes: Real‐world evidence and the case for stricter glycaemic targets
Cohort studyTechnology
Diabetes Obes Metab4 Feb 2025
Survey among adult users of semaglutide for weight loss in Denmark: User characteristics, treatment expectations and experienced effects
Cross-sectional studyObesity
Diabetes Obes Metab3 Feb 2025
Fibroblast growth factor 23 predicts incident diabetic kidney disease: A 4.6‐year prospective study
Cohort studyComplications
Diabetes Obes Metab30 Jan 2025
Targeted metabolomics reveals novel biomarkers for gestational diabetes mellitus
Case-control studyDiabetes in pregnancy
Diabetes Obes Metab30 Jan 2025
Clinical effectiveness and cost‐effectiveness of first‐line early combination of dipeptidyl peptidase 4 inhibitors and metformin in patients with type 2 diabetes in Taiwan: A modelling study
Research articleT2D & other
Diabetes Obes Metab30 Jan 2025
Comparative effectiveness of insulin glargine, glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter‐2 inhibitors in veterans with type 2 diabetes
Cohort studyT2D & other
Diabetes Obes Metab30 Jan 2025
Recognition of ophthalmology consultation and fundus examination among individuals with diabetes in Japan: A cross‐sectional study using claims‐questionnaire linked data
Cross-sectional studyComplications
Diabetes Obes Metab27 Jan 2025
Impact of time in tight range on all‐cause and cardiovascular mortality in type 2 diabetes: A prospective cohort study
Cohort studyT2D & other
Diabetes Obes Metab27 Jan 2025
Postprandial time in tight range with faster insulin aspart compared with standard insulin aspart in youth with type 1 diabetes using automated insulin delivery
Secondary analysisTechnology
Diabetes Obes Metab24 Jan 2025
Evaluation of the analytical and clinical accuracy of four blood glucose meters in pregnant women with hyperglycaemia
Diagnostic or prognostic studyDiabetes in pregnancy
Diabetes Obes Metab22 Jan 2025
Achievement of HbA1c and weight targets in adults with type 2 diabetes on once weekly injectable glucagon‐like peptide‐1 receptor agonist therapy in UK primary care: A retrospective, real‐world study
Cohort studyT2D & other
Diabetes Obes Metab22 Jan 2025
The safety, tolerability, pharmacokinetics and pharmacodynamics of an optimized dual GLP ‐1/ GIP receptor agonist ( BGM0504 ) in healthy volunteers: A dose‐escalation Phase I study
Randomized controlled trialT2D & other
Diabetes Obes Metab22 Jan 2025
Association of GLP1R locus with mental ill‐health endophenotypes and cardiometabolic traits: A trans‐ancestry study in UK Biobank
Meta-analysisT2D & other
Diabetes Obes Metab20 Jan 2025
Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system
Meta-analysisTechnology
Diabetes Obes Metab20 Jan 2025
Safety and effectiveness in an uncontrolled setting of glucagon‐like‐peptide‐1 receptor agonists in patients with familial partial lipodystrophy: Real‐life experience from a national reference network
Cohort studyObesity
Diabetes Obes Metab19 Jan 2025
Beyond glycated haemoglobin: Modelling contemporary management of type 2 diabetes with the updated Cardiff model
Research articleT2D & other
Diabetes Obes Metab16 Jan 2025
Prognostic value of changes in vibration‐controlled transient elastography parameters for liver, cardiovascular and mortality outcomes in individuals with type 2 diabetes and metabolic dysfunction‐associated steatotic liver disease: The Rio de Janeiro type 2 diabetes cohort
Cohort studyT2D & other
Diabetes Obes Metab16 Jan 2025
Subgroup analysis by sex and baseline BMI in people with a BMI ≥27 kg/m 2 in the phase 2 trial of survodutide, a glucagon/ GLP ‐1 receptor dual agonist
Secondary analysisObesity
Diabetes Obes Metab16 Jan 2025
Exploring the link between inflammation and brain function after metabolic‐bariatric surgery: A year‐long fMRI study
Mechanistic studyObesity
Diabetes Obes Metab15 Jan 2025
Apolipoprotein CIII correlates with lipoproteins in the fed state and is not regulated by leptin administration in states of hypoleptinemia induced by acute or chronic energy deficiency: Results from two randomised controlled trials
Secondary analysisLipids & liver
Diabetes Obes Metab15 Jan 2025
Baseline and cumulative Chinese visceral adiposity index and diabetic kidney disease: A prospective cohort study
Cohort studyComplications
Diabetes Obes Metab15 Jan 2025
Association of changes in the type 2 diabetes and MASLD /related SLD status with risk of developing cardiovascular disease
Cohort studyT2D & other
Diabetes Obes Metab13 Jan 2025
Effect of insulin sensitivity, insulin secretion, and beta cell function on the remission of type 2 diabetes: A post hoc analysis of the IDEATE trial
Secondary analysisT2D & other
Diabetes Obes Metab13 Jan 2025
Effects of the SGLT2 inhibitor ipragliflozin and metformin on hepatic steatosis and liver fibrosis: Sub‐analysis of a randomized controlled study
Secondary analysisT2D & other
Diabetes Obes Metab13 Jan 2025
Risk of insulin initiation with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes mellitus: A real‐world claims database study in Japan
Cohort studyT2D & other
Diabetes Obes Metab13 Jan 2025
Trends and analysis of risk factor differences in the global burden of chronic kidney disease due to type 2 diabetes from 1990 to 2021: A population‐based study
Cohort studyComplications
Diabetes Obes Metab13 Jan 2025
Unexpected cardiovascular risks of glucagon‐like peptide‐1 receptor agonist and aspirin co‐administration in individuals with obesity, with and without type 2 diabetes: A propensity score matched cohort study
Cohort studyObesity
Diabetes Obes Metab10 Jan 2025
Impact of a very low‐calorie ketogenic diet on metabolic and microbiota outcomes in post‐bariatric patients and bariatric‐Naïve individuals: A comparative pilot study
Case-control studyObesity
Diabetes Obes Metab10 Jan 2025
Real‐world retrospective study in elderly patients aged 65 years and older with type 2 diabetes mellitus treated with daily oral semaglutide ( SEMA ‐elderly)
Cohort studyT2D & other
Diabetes Obes Metab9 Jan 2025
Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial
Meta-analysisT2D & other
Diabetes Obes Metab9 Jan 2025
Metabolic dysfunction‐associated steatotic liver disease and cancer risk: A cohort study
Cohort studyLipids & liver
Diabetes Obes Metab9 Jan 2025
Efficacy of myo‐inositol and zinc on insulin resistance in a paediatric population with obesity
Randomized controlled trialObesity
Diabetes Obes Metab9 Jan 2025
Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT ‐1 to ‐4 trials
Secondary analysisObesity
Diabetes Obes Metab8 Jan 2025
Long‐term health benefit and economic return of time in range ( TIR ) improvement in individuals with type 2 diabetes
Research articleT2D & other
Diabetes Obes Metab8 Jan 2025
Association of Metformin use with risk of dementia in patients with type 2 diabetes: A systematic review and meta‐analysis
Meta-analysisT2D & other
Diabetes Obes Metab8 Jan 2025
Impact of TCF7L2 rs7903146 on clinical presentation and risk of complications in patients with type 2 diabetes
Cohort studyT2D & other
Diabetes Obes Metab7 Jan 2025
Real‐time continuous glucose monitoring improves postoperative glucose control in people with type 2 diabetes mellitus undergoing coronary artery bypass grafting: A randomized clinical trial
Randomized controlled trialTechnology
Diabetes Obes Metab7 Jan 2025
MicroRNA ‐mediated Ets1 repression in retinal endothelial cells: A novel anti‐angiogenic mechanism in nonproliferative diabetic retinopathy
Case-control studyComplications

All 2,200 Briefs in ExploreShowing Briefs 1,241–1,280 of 2,200, newest first